Earnings Feed
Start Free
Bellerophon Therapeutics, Inc.·4

Sep 14, 4:03 PM ET

BENNETT MATTHEW 4

4 · Bellerophon Therapeutics, Inc. · Filed Sep 14, 2020

Insider Transaction Report

Form 4
Period: 2020-09-10
Bellerophon Therapeutics, Inc.BLPH
BENNETT MATTHEW
Director
Transactions
  • Award

    Stock Option (right to buy)

    2020-09-10$10.12/sh+6,509$65,871→ 6,509 total
    Exercise: $10.12From: 2021-09-10Exp: 2030-09-10→ Common Stock (6,509 underlying)

Documents

1 file
  • 4
    wf-form4_160011377704263.xmlPrimary

    FORM 4